Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NOTCH1 Signalling: A key pathway for the development of high-risk chronic lymphocytic leukaemia. | Front Oncol | 2022 | 36313682 | PubTator, text mining | PubMed |
| A homogalacturonan from Lonicera japonica Thunb. disrupts angiogenesis via epidermal growth factor receptor and Delta-like 4 associated signaling. | Glycoconj J | 2022 | 36306024 | PubTator, text mining | PubMed |
| Heart failure and cancer: From active exposure to passive adaption. | Front Cardiovasc Med | 2022 | 36304546 | PubTator, text mining | PubMed |
| Comprehensive analysis of potential cellular communication networks in advanced osteosarcoma using single-cell RNA sequencing data. | Front Genet | 2022 | 36303551 | PubTator, text mining | PubMed |
| Antibody therapeutics for epithelial ovarian cancer. | Expert Opin Biol Ther | 2022 | 36302510 | PubTator, text mining | PubMed |
| Targeting aldehyde dehydrogenase for prostate cancer therapies. | Front Oncol | 2022 | 36300093 | PubTator, text mining | PubMed |
| Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers. | Front Oncol | 2022 | 36300092 | PubTator, text mining | PubMed |
| Brain Microvascular Endothelial Cell-Derived Exosomes Protect Neurons from Ischemia-Reperfusion Injury in Mice. | Pharmaceuticals (Basel) | 2022 | 36297399 | PubTator, text mining | PubMed |
| Glioblastoma-Specific Strategies of Vascularization: Implications in Anti-Angiogenic Therapy Resistance. | J Pers Med | 2022 | 36294763 | PubTator, text mining | PubMed |
| New Insight on 2D In Vitro Angiogenesis Models: All That Stretches Is Not a Tube. | Cells | 2022 | 36291145 | PubTator, text mining | PubMed |
| Engineering Spatiotemporal Control in Vascularized Tissues. | Bioengineering (Basel) | 2022 | 36290523 | PubTator, text mining | PubMed |
| Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer. | Curr Issues Mol Biol | 2022 | 36286020 | PubTator, text mining | PubMed |
| Notch signaling and fluid shear stress in regulating osteogenic differentiation. | Front Bioeng Biotechnol | 2022 | 36277376 | PubTator, text mining | PubMed |
| Genetic insights into non-syndromic Tetralogy of Fallot. | Front Physiol | 2022 | 36277185 | PubTator, text mining | PubMed |
| Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma. | Oncol Lett | 2022 | 36276500 | PubTator, text mining | PubMed |
| Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed. | Front Immunol | 2022 | 36275669 | PubTator, text mining | PubMed |
| Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment. | Nat Commun | 2022 | 36271074 | PubTator, text mining | PubMed |
| Cancer-associated Notch receptor variants lead to O-fucosylation defects that deregulate Notch signaling. | J Biol Chem | 2022 | 36265581 | PubTator, text mining | PubMed |
| Knockdown of Long Noncoding RNA LINC00240 Inhibits Esophageal Cancer Progression by Regulating miR-26a-5p. | Contrast Media Mol Imaging | 2022 | 36262998 | PubTator, text mining | PubMed |
| A Versatile Biomimic Nanotemplating Fluidic Assay for Multiplex Quantitative Monitoring of Viral Respiratory Infections and Immune Responses in Saliva and Blood. | Adv Sci (Weinh) | 2022 | 36253095 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=40